Morgan Stanley raised the target price for Seazen (01030) to HKD2.22 from HKD1.97 and maintained the "equal-weight" rating.
The research house said it lifts core earnings estimates by 4.1% for 2025, 3.0% for 2026, and 2.6% for 2027, partially offset by weaker-than-expected savings in SG&A and interest expenses.
樂本健 x etnet健康網購 | 憑獨家優惠碼【ETN2508】,購物滿$500即送免費禮品► 了解詳情